Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0.08EBIT per Share
VS
Market
Sector
Industry
History
$ 8.3Close
$ 6.41 - $ 16.8 52-Week Range
Ticker Information
Ticker
GYRECompany Name
GYRE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQGYRE THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
GYRE - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ 7M | $ 0.08 | 1 | 89.12M |
| 3/31/2025 | $ 10.93M | $ 0.13 | 1 | 86.42M |
| 12/31/2024 | $ 17.41M | $ 0.2 | 1 | 85.09M |
| 9/30/2024 | $ -63.34M | $ -0.74 | 1 | 85.64M |
| 6/30/2024 | $ -67.12M | $ -0.78 | 1 | 85.5M |
| 3/31/2024 | $ -74.61M | $ -0.9 | 1 | 83.27M |
| 12/31/2023 | $ -84.42M | $ -1.28 | 1 | 65.83M |
| 9/30/2023 | $ -43.88M | $ -17.33 | 1 | 2.53M |
| 6/30/2023 | $ -47.19M | $ -18.72 | 1 | 2.52M |
| 3/31/2023 | $ 6.92M | $ 2.75 | 1 | 2.52M |
Key Performance Insights, Last 5 Years
- GYRE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -34.62.
- Over the past 5 years, GYRE THERAPEUTICS INC's average EBITPS has been $ -15.82.
- The median EBITPS for GYRE THERAPEUTICS INC during this period was $ -3.9
- GYRE THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ 5.66.
- The lowest EBITPS recorded by GYRE THERAPEUTICS INC in the same timeframe $ -43.99
GYRE THERAPEUTICS INC's EBITPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITPS Benchmarks
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for GYRE THERAPEUTICS INC is calculated as follows: EBIT [ $ -50.94M ] / (Shares WA [ 1.47M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -34.62 ] GYRE - EBIT per Share, Last 5 years
$ -43.99
Minimum
Dec 31, 2020
$ 5.66
Maximum
Sep 30, 2022
$ -15.82
Average
$ -3.9
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.41.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.71 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.39 |
| std | $ 3.41 |